Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kohen

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1996
Movement disorder in Down's syndrome: a possible marker of the severity of mental handicapC M Haw, T R Barnes, K Clark, et al.
Bulletin Des Societes D'Ophtalmologie De France|April 1, 1982
[Uveitis in a Yersinia pseudotuberculosis infection--one case]P Girard, J J Saragoussi, C Merlet, et al.
BMJ (Clinical Research Ed.)|April 20, 1996
Supervised discharge is anachronisticT H Turner, E Akuffo, P Caviston, et al.
European Journal of Human Genetics : EJHG|July 4, 2001
Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1)E Blaveri, G Kalsi, J Lawrence, et al.
International Clinical Psychopharmacology|September 1, 1994
Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research GroupP de Koning, M Mak, M H de Vries, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1996
Movement disorder in Down's syndrome: a possible marker of the severity of mental handicapC M Haw, T R Barnes, K Clark, et al.
Bulletin Des Societes D'Ophtalmologie De France|April 1, 1982
[Uveitis in a Yersinia pseudotuberculosis infection--one case]P Girard, J J Saragoussi, C Merlet, et al.
BMJ (Clinical Research Ed.)|April 20, 1996
Supervised discharge is anachronisticT H Turner, E Akuffo, P Caviston, et al.
European Journal of Human Genetics : EJHG|July 4, 2001
Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1)E Blaveri, G Kalsi, J Lawrence, et al.
International Clinical Psychopharmacology|September 1, 1994
Eltoprazine in aggressive mentally handicapped patients: a double-blind, placebo- and baseline-controlled multi-centre study. The Eltoprazine Aggression Research GroupP de Koning, M Mak, M H de Vries, et al.
Pageof 4